24. Achievements Through Hemovigilance

  1. René R. P. De Vries MD2 and
  2. Jean-Claude Faber MD3
  1. Jean-Claude Faber MD3 and
  2. Fátima Nascimento MD1

Published Online: 6 AUG 2012

DOI: 10.1002/9781118338179.ch24

Hemovigilance: An Effective Tool for Improving Transfusion Safety

Hemovigilance: An Effective Tool for Improving Transfusion Safety

How to Cite

Faber, J.-C. and Nascimento, F. (2012) Achievements Through Hemovigilance, in Hemovigilance: An Effective Tool for Improving Transfusion Safety (eds R. R. P. De Vries and J.-C. Faber), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781118338179.ch24

Editor Information

  1. 2

    Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

  2. 3

    Blood Transfusion Service of the Luxembourg Red Cross, Luxembourg

Author Information

  1. 1

    Transfusion Medicine General Directorate of Health Lisbon, Portugal

  2. 3

    Blood Transfusion Service of the Luxembourg Red Cross, Luxembourg

Publication History

  1. Published Online: 6 AUG 2012
  2. Published Print: 29 AUG 2012

ISBN Information

Print ISBN: 9780470655276

Online ISBN: 9781118338179

SEARCH

Keywords:

  • achievements;
  • achievements through hemovigilance;
  • HV, increased transfusion safety and improved quality;
  • “Action” approaches in terms of CAPA, similar or standardized;
  • longitudinal analysis using UK data;
  • UK's SHOT, one of the oldest HV systems in place;
  • adverse reactions, ATR, HTR, TRALI as clinical situations after transfusion;
  • actions and measures, triggered by hemovigilance;
  • usage segment in healthcare institution;
  • pharmaceutical principle of “highest purity” leitmotiv for the BE

Summary

This chapter contains sections titled:

  • Introduction

  • Methods

  • Longitudinal analysis using UK data

  • Results

  • Conclusions

  • Acknowledgements

  • References